321
Views
15
CrossRef citations to date
0
Altmetric
Research Articles

Preparation, optimization, and in-vitro characterization of α-tocopherol-loaded solid lipid nanoparticles (SLNs)

, & ORCID Icon
Pages 159-171 | Received 02 Jul 2019, Accepted 05 Dec 2019, Published online: 13 Jan 2020

References

  • Brigelius-Flohe R, Galli F. Vitamin E: a vitamin still awaiting the detection of its biological function. Mol Nutr Food Res. 2010;54:583–587.
  • Zingg JM, Azzi A. Non-antioxidant activities of vitamin E. Curr Med Chem. 2004;11(9):1113–1133.
  • Golli F, Azzi A. Present trends in vitamin E research. Biofactors. 2010;36:33–42.
  • Rigotti A. Absorption, transport, and tissue delivery of vitamin E. Mol Aspects Med. 2007;28(5–6):423–436.
  • McClements DJ, Decker EA, Park Y, et al. Structural design principles for delivery of bioactive components in nutraceuticals and functional foods. Crit Rev Food Sci Nutr. 2009;49(6):577–606.
  • Yang ZY, Huffman SL. Review of fortified food and beverage products for pregnant and lactating women and their impact on nutritional status. Matern Child Nutr. 2011;7:19–43.
  • Gawrysiak-Witulska M, Siger A, Nogala-Kalucka M. Degradation of tocopherols during near-ambient rapeseed drying. J Food Lipids. 2009;16(4):524–539.
  • Yoon Y, Choe E. Lipid oxidation and stability of tocopherols and phospholipids in soy added fried products during storage in the dark. Food Sci Biotechnol. 2009;18:356–361.
  • Nada AH, Zaghloul AA, Hedaya MA, et al. Stability of vitamin E and vitamin E acetate containing cosmetic preparations. J Glob Pharm Technol. 2012;4:1–8.
  • Duhem N, Danhier F, Préat V. Vitamin E-based nanomedicines for anti-cancer drug delivery. J Control Release. 2014;182:33–44.
  • Velikov KP, Pelan E. Colloidal delivery systems for micronutrients and nutraceuticals. Soft Matter. 2008;4(10):1964–1980.
  • Gonnet M, Lethuaut L, Boury F. New trends in encapsulation of liposoluble vitamins. J Control Release. 2010;146(3):276–290.
  • Lesmes U, McClements DJ. Structure–function relationships to guide rational design and fabrication of particulate food delivery systems. Trends Food Sci Technol. 2009;20(10):448–457.
  • Gonçalves RFS, Martins JT, Duarte CMM, et al. Microemulsions: advances in nutraceutical delivery systems: from formulation design for bioavailability enhancement to efficacy and safety evaluation. Trends Food Sci Technol. 2018;78:270–291.
  • Matalanis A, Jones OG, McClements DJ. Structured biopolymer-based delivery systems for encapsulation, protection, and release of lipophilic compounds. Food Hydrocoll. 2011;25(8):1865–1880.
  • Kalepu S, Manthina M, Padavala V. Oral lipid-based drug delivery systems – an overview. Acta Pharm Sin B. 2013;3(6):361–372.
  • O’Callaghan Y, O’Brien N. Bioaccessibility, cellular uptake and transepithelial transport of alpha-tocopherol and retinol from a range of supplemented foodstuffs assessed using the Caco-2 cell model. Int J Food Sci Technol. 2010;45:1436–1442.
  • Borel P, Preveraud D, Desmarchelier C. Bioavailability of vitamin E in humans: an update. Nutr Rev. 2013;71(6):319–331.
  • Wilburn EE, Mahan DC, Hill DA, et al. An evaluation of natural (RRR-α-tocopheryl acetate) and synthetic (all-rac-α-tocopheryl acetate) vitamin E fortification in the diet or drinking water of weanling pigs. J Anim Sci. 2008;86(3):584–591.
  • Dersjant-Li Y, Peisker M. A critical review of methodologies used in determination of relative bio-availability ratio of RRR-α-tocopheryl acetate and all-rac-α-tocopheryl acetate. J Sci Food Agric. 2010;90(10):1571–1577.
  • Jensen SK, Lauridsen C. Alpha-tocopherol stereoisomers. Vitam Horm. 2007;76:281–308.
  • Burton GW, Traber MG. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr. 1990;10(1):357–382.
  • Herrero-Barbudo MC, Granado-Lorencio F, Blanco-Navarro I, et al. Applicability of an in vitro model to assess the bioaccessibility of vitamins A and E from fortified commercial milk. Int Dairy J. 2009;19(1):64–67.
  • Brisson L, Castan S, Fontbonne H, et al. Alpha-tocopheryl acetate is absorbed and hydrolyzed by Caco-2 cells: comparative studies with alpha-tocopherol. Chem Phys Lipids. 2008;154(1):33–37.
  • Nair R, Kumar ACK, Priya VK, et al. Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine. Lipids Health Dis. 2012;11(1):72–80.
  • Simonoska CM, Geskovski N, Calis S, et al. Definition of formulation design space, in vitro bioactivity and in vivo biodistribution for hydrophilic drug loaded PLGA/PEO-PPO-PEO nanoparticles using OFAT experiments. Eur J Pharm Sci. 2013;49:65–80.
  • Kumar VV, Chandrasekar D, Ramakrishna S, et al. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm. 2007;335(1–2):167–175.
  • Xie S, Zhu L, Dong Z, et al. Preparation, characterization and pharmacokinetics of enrofloxacin-loaded solid lipid nanoparticles: influences of fatty acids. Colloids Surf B Biointerfaces. 2011;83(2):382–387.
  • Reddy LH, Murthy R. Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation. AAPS PharmSciTech. 2005;6:E158–E166.
  • Haley H, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol. 2008;26(1):57–64.
  • Zheng D, Li X, Xu H, et al. Study on docetaxel-loaded nanoparticles with high antitumor efficacy against malignant melanoma. Acta Biochim Biophys Sin. 2009;41(7):578–587.
  • Siddiqui IA, Bharali DJ, Nihal M, et al. Excellent antiproliferative and pro-apoptotic effects of (−)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomedicine. 2014;10(8):1619–1626.
  • Yu S, Xu X, Feng J, et al. Chitosan and chitosan coating nanoparticles for the treatment of brain disease. Int J Pharm. 2019;560:282–293.
  • Das RK, Kasoju N, Bora U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine. 2010;6(1):153–160.
  • Zhao B, Yin JJ, Bilski PJ, et al. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Toxicol Appl Pharmacol. 2009;241(2):163–172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.